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at www.jvascsurg.org.DISCUSSIONDr Zachary Arthurs (San Antonio, Tex). My interpretation
of your results is a little different. The real question at hand is,
For juxtarenal aneurysms, should a three-vessel device be the
design of choice or a two-vessel design? You chose to include
the pararenal aneurysms, so my interpretation is really that a
two-vessel design with a scallop will ﬁt most juxtarenal aneurysms,
and a three-vessel design with a scallop will ﬁt most pararenal an-
eurysms. The ﬁrst paper this morning demonstrated that when you
do include that third superior mesenteric artery (SMA) fenestra-
tion, the mortality goes up exponentiallyd9.5% in that report.
So my question to you is, How many patients with juxtarenal an-
eurysms could have been treated with a two-vessel device vs the
three-vessel device?
Dr Bernardo C. Mendes. The Endologix Ventana system
was better to treat juxtarenal aneurysms compared with pararenal
aneurysms. This makes sense since a 15-mm healthy aortic neck
is required for the proximal sealing zone achievement. With the
Ventana device, strict anatomic feasibility for juxtarenal aneurysms
was 34%; and for pararenal aneurysms, it was only 10%. For both
combined, the Ventana device was suitable in 26% of patients. Us-
ing liberal criteria, we can treat 63% of juxtarenal aneurysms and
14% of pararenal aneurysms with the Ventana stent graft. In the
majority of patients, the distance between the highest renal arteryand the SMA was >15 mm, therefore explaining the high suit-
ability of Ventana for juxtarenal aneurysms. Nonetheless, let’s
keep in mind that juxtarenal aneurysms represent only 43% of all
complex abdominal aortic aneurysms. For the Cook p-Branch,
there is not a signiﬁcant difference between treating patients
with pararenal and juxtarenal aneurysms; the device has similar
application for both. So to answer your question, the Ventana stent
graft designed with two fenestrations and a scallop is a device that
is more suitable for juxtarenal aneurysms, but this represents the
minority of all cases that need fenestrated incorporation.
Dr Mark Farber (Chapel Hill, NC). My question refers to
the patients that you excluded and why you say we use strict
anatomic criteria for looking at the proximal neck. How many of
those patients in your practice, that you see a little diameter change
of the SMA aorta compared to the infrarenal aorta, did you
exclude? If you had included those, what is the overall percentage
of patients that you see, and do you have any data for which pa-
tients you treated with the Cook ZFEN device that are in short
necks? If you gave that entire population a look, how many would
be excluded, how many for the Ventana, how many for the p-
Branch, how many for the ZFEN?
Dr Mendes. In response to your second question, we have
not analyzed the feasibility of the Cook ZFEN in this study. The
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gational off-the-shelf designs, Ventana and p-Branch.
The ﬁrst question addresses the issue of neck selection. We
were very meticulous in the selection of the aneurysm neck,
regardless of where it was located within the aorta (eg, juxtarenal,
pararenal, paravisceral, or type IV thoracoabdominal aneurysm).
We deﬁned as normal aortic parallel, healthy aortic walls with min-
imal or no thrombus or calcium and <10% diameter change over a
2-cm length. This corresponds to our current standard practice
when selecting and planning a fenestrated repair. We do not
compromise on this concept. Therefore, a patient was considered
pararenal if the neck extended up to the lower aspect of the
SMA, and juxtarenal if the neck started at the level of the renal ar-
teries. Above these respective levels, the aorta was normal, parallel,
with no aneurysm. Your question addresses a common phenome-
non, which is slight dilation of the posterior aorta behind the SMA,
compared with the infrarenal aorta. We considered this slight dila-
tion as aneurysm and not as normal aorta and planned in these
cases the landing zone above the SMA, where it became
completely parallel. The ﬁnal message is that we used the strict cri-
terion for proximal neck as we do not advertise that the proximal
sealing zone should be compromised. We believe, as others do,
that aortic disease follows a progressive course and that therapeutic
options in an eventual longitudinal progression of the disease are
complex and limited.
Dr Mark Fillinger (Lebanon, NH). First, a comment, which
is to encourage everyone who does this type of research to follow
the Society for Vascular Surgery (SVS) reporting standards because
it gets confusing when we talk about juxtarenal, pararenal, perivisc-
eral, and thoracoabdominal aneurysms.
I used to use the same deﬁnitions that you presented here,
meaning a thoracoabdominal aortic aneurysm had to involve upto the celiac origin. When we set out to write the deﬁnitions
into the thoracic endovascular aortic repair standards, however, I
had an argument with one of the other people on the committee,
who said, “thoracoabdominal aneurysms are anything that involve
the renals and above.“ And I said, ”No, that’s not true. I can show
you pictures in books.” So I went back to the original papers by
Crawford, because I was trying to prove them wrong, and it turned
out they were right, using the text deﬁnitions in Crawford’s orig-
inal papers. The “they” in this story is Roy Greenberg, by the way.
So the point is, a percentage of your patients that are not
meeting the criteria for “juxtarenal” devices appear to be better
characterized as type IV thoracoabdominal aneurysms, which
would require four branch repairs. Is that correct or am I misun-
derstanding your deﬁnitions?
Dr Mendes. I agree, we have used the SVS reporting stan-
dards for infrarenal EVAR and acknowledge there is not a report-
ing standard for fenestrated repair. The percentages of patients that
were analyzed in this study represent the target population of these
two devices for pararenal and juxtarenal populations. Using one of
the two devices in 390 patients with juxtarenal or pararenal aneu-
rysms, strict criteria were met in 43% and liberal criteria in 63%.
In response to your question, we have not included type IV
thoracoabdominal aneurysms nor paravisceral (above the SMA)
aneurysms in the speciﬁc feasibility analysis of Ventana and
p-Branch. The analysis was done in juxtarenal and pararenal aneu-
rysms, which corresponded to 390 patients or 75% of all complex
abdominal aortic aneurysms. However, we collected the number
of patients with type IV thoracoabdominal aneurysms or paravisceral
aneurysms so we can have an idea of the total denominator of com-
plex abdominal aneurysms in our practice. If we use the whole com-
plex aortic aneurysm population, which includes aneurysms with
extension above the SMA, the suitability would be even lower.
